# Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

## TL;DR

This review explains how cells respond to low oxygen and oxidative stress in cancer through HIF and NRF2 proteins, and how these responses can be targeted for new cancer treatments.

## Contribution

The paper highlights the collaborative and adaptive roles of HIFs and NRF2 in cancer progression and proposes targeting these pathways as a novel treatment strategy.

## Key findings

- HIFs and NRF2 signaling pathways adapt to hypoxia and oxidative stress in tumors.
- The interplay between HIFs and NRF2 contributes to cancer cell survival and treatment resistance.
- Targeting HIF and NRF2 pathways may offer new cancer therapies, especially in hypoxic tumors.

## Abstract

Oxygen is crucial for life and acts as the final electron acceptor in mitochondrial energy production. Cells adapt to varying oxygen levels through intricate response systems. Hypoxia-inducible factors (HIFs), including HIF-1α and HIF-2α, orchestrate the cellular hypoxic response, activating genes to increase the oxygen supply and reduce expenditure. Under conditions of excess oxygen and resulting oxidative stress, nuclear factor erythroid 2-related factor 2 (NRF2) activates hundreds of genes for oxidant removal and adaptive cell survival. Hypoxia and oxidative stress are core hallmarks of solid tumors and activated HIFs and NRF2 play pivotal roles in tumor growth and progression. The complex interplay between hypoxia and oxidative stress within the tumor microenvironment adds another layer of intricacy to the HIF and NRF2 signaling systems. This review aimed to elucidate the dynamic changes and functions of the HIF and NRF2 signaling pathways in response to conditions of hypoxia and oxidative stress, emphasizing their implications within the tumor milieu. Additionally, this review explored the elaborate interplay between HIFs and NRF2, providing insights into the significance of these interactions for the development of novel cancer treatment strategies.

In our daily lives, oxygen is vital for survival, but its levels can vary due to environmental shifts or within our bodies, such as in diseases like heart disease or cancer. However, excess oxygen can also be detrimental, leading to a condition called oxidative stress. Cells have evolved systems to adapt to these fluctuating oxygen levels, with key roles played by proteins named hypoxia-inducible factors (HIFs) and nuclear factor erythroid 2-related factor 2 (NRF2). These factors aid cells’ survival by activating different and overlapping genes that can enhance oxygen supply or shield against damage. This study discovered that HIFs and NRF2 can occasionally collaborate to aid cancer cells’ growth and treatment resistance. The key discoveries suggest that targeting these pathways could be a novel approach to cancer treatment, especially in tumors that have adapted to low oxygen conditions.

This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.